The benefits and harms of oral iron supplementation in non-anaemic pregnant women: a systematic review and meta-analysis
Watt A., Eaton H., Eastwick-Jones K., Thomas ET., Plüddemann A.
Background: Iron deficiency during pregnancy poses a significant risk to both maternal and foetal health. Current international guidelines provide discrepant advice on antenatal iron supplementation for non-anaemic women. Objective: We aimed to quantify the benefits and harms of routine antenatal supplementation in non-anaemic women. Methods. The Cochrane Library, MEDLINE, Embase, and clinical trial registries were searched for randomized controlled trials and observational studies comparing oral iron supplementation with placebo or no supplement in non-anaemic pregnant women. Risk of bias was assessed for each study and the results were synthesized via meta-analysis. Results: Twenty-three eligible studies were identified with 4492 non-anaemic pregnant women. Supplemented groups had higher haemoglobin [mean difference = 6.95 g/l, 95% confidence interval (CI): 4.81–9.09, P